Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Current Deferred Revenue (2017 - 2025)

Historic Current Deferred Revenue for cbdMD (YCBD) over the last 8 years, with Q4 2025 value amounting to $488626.0.

  • cbdMD's Current Deferred Revenue fell 735.86% to $488626.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $488626.0, marking a year-over-year decrease of 735.86%. This contributed to the annual value of $506289.0 for FY2025, which is 60.31% up from last year.
  • According to the latest figures from Q4 2025, cbdMD's Current Deferred Revenue is $488626.0, which was down 735.86% from $506289.0 recorded in Q3 2025.
  • Over the past 5 years, cbdMD's Current Deferred Revenue peaked at $557353.0 during Q1 2025, and registered a low of $755.0 during Q2 2021.
  • Moreover, its 4-year median value for Current Deferred Revenue was $504771.5 (2024), whereas its average is $429667.4.
  • In the last 5 years, cbdMD's Current Deferred Revenue surged by 17166.79% in 2024 and then plummeted by 742.58% in 2025.
  • cbdMD's Current Deferred Revenue (Quarter) stood at $755.0 in 2021, then soared by 24435.89% to $185246.0 in 2023, then skyrocketed by 184.72% to $527438.0 in 2024, then fell by 7.36% to $488626.0 in 2025.
  • Its Current Deferred Revenue was $488626.0 in Q4 2025, compared to $506289.0 in Q3 2025 and $509198.0 in Q2 2025.